N2-Trityl Olmesartan Acid CAS 752179-89-8 Kemurnian >98,0% (HPLC) Olmesartan Medoxomil Intermediate Factory
Pasokan Kimia Ruifu Olmesartan Medoxomil Intermediet Kanthi Kualitas Tinggi:
4,5-Dimetil-1,3-Dioxol-2-Siji (DMDO) CAS 37830-90-3
4-Chloromethyl-5-Methyl-1,3-Dioxol-2-One (DMDO-Cl) CAS 80841-78-7
Etil 4-(1-Hydroxy-1-Methylethyl)-2-Propyl-Imidazole-5-Carboxylate CAS 144689-93-0
Dietil 2-Propil-1H-Imidazole-4,5-Dikarboksilat CAS 144689-94-1
Trityl Olmesartan Ethyl Ester CAS 144690-33-5
Trityl Olmesartan Asam CAS 761404-85-7
N2-Trityl Olmesartan Asam CAS 752179-89-8
Trityl Olmesartan Medoxomil CAS 144690-92-6
Olmesartan Medoxomil CAS 144689-63-4
Jeneng Kimia | N2-Trityl Olmesartan Asam |
sinonim | Asam Tritil Olmesartan (N2);Olmesartan N2-Trityl Impurity;4-(1-Hydroxy-1-Methylethyl)-2-Propyl-1-[[2'-[2-(triphenylmethyl)-2H-tetrazol-5-yl][1,1'-biphenyl]-4-yl ]metil]-1H-Imidazole-5-Asam Karboksilat;4-(2-Hydroxypropan-2-yl)-2-Propyl-1-((2'-(2-tritil-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl) metil)-1H-Imidazole-5-Asam Karboksilat |
Nomer CAS | 752179-89-8 |
Nomer CAT | RF-PI1876 |
Status Simpenan | Ing Simpenan, Skala Produksi Nganti Ton |
Formula Molekul | C43H40N6O3 |
Bobot Molekul | 688.82 |
Merk | Kimia Ruifu |
Item | Spesifikasi |
Penampilan | Bubuk Putih nganti Putih |
Kemurnian / Metode Analisis | > 98,0% (HPLC) |
Mundhut ing Pangatusan | <1.00% |
Sisa ing Ignition | <0,50% |
Impurity Tunggal | <1.00% |
Total Impurities | <2.00% |
Logam Berat (Pb) | <20 ppm |
Test Standar | Standar Perusahaan |
Panggunaan | Penengah Olmesartan Medoxomil (CAS: 144689-63-4) |
Paket: Botol, tas Aluminium foil, 25kg / Karton Drum, utawa miturut kabutuhan pelanggan
Kondisi panyimpenan:Simpen ing wadhah sing disegel ing papan sing adhem lan garing;Nglindhungi saka cahya lan Kelembapan
N2-Trityl Olmesartan Acid (CAS: 752179-89-8) minangka penengah ing sintesis Olmesartan Medoxomil (CAS: 144689-63-4) senyawa sing gegandhengan.Olmesartan Medoxomil minangka antagonis reseptor angiotensin II sing digunakake kanggo perawatan tekanan darah tinggi.Olmesartan Medoxomil minangka prodrug saka Olmesartan, minangka inhibitor reseptor angiotensin II tipe 1 (AT1) sing nyegah umpan balik regulasi negatif babagan sekresi renin, nyuda sekresi aldosteron lan nyebabake nyuda resistensi vaskular periferal (vasodilasi).Senyawa iki nduweni aktivitas antihipertensi, kardioprotektif, vasodilatasi, lan anti-inflamasi.Olmesartan Medoxomil bisa digunakake dhewe utawa digabungake karo agen antihipertensi liyane.Ing studi klinis komparatif ing pasien hipertensi esensial, Olmesartan nyuda tekanan diastolik ing cuff lungguh luwih akeh tinimbang Losartan, Valdesartan lan Ibesartan, dene nyuda tekanan getih sistolik padha kanggo kabeh perawatan.